Drug Industry Balks At Obama's Budget Proposals

Law360, New York (February 13, 2012, 6:34 PM EST) -- The pharmaceutical industry found itself a potential loser Monday in President Barack Obama's proposed 2013 budget, even as U.S. Food and Drug Administration officials vowed to use a $654 million boost in spending — nearly all of it from user fees — to speed reviews of drugs and devices.

The budget proposes several initiatives that the industry strongly opposes: changing Medicare Part D rebates, shortening the exclusivity period for biological drugs and ending “pay for delay” agreements between drug companies.

First, the president's budget would change...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.